Breastfeeding News and Research

Latest Breastfeeding News and Research

Data shows Victoza produces greater reductions in A1c, body weight and FPG than Januvia

Late-breaking Novo Nordisk extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association showed that once-daily Victoza in combination with metformin produced sustained and significantly greater reductions in A1c, body weight and fasting plasma glucose than Januvia plus metformin at 52 weeks.

28 Jun 2010

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. DULERA is not indicated for the relief of acute bronchospasm. DULERA combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate).

24 Jun 2010

Study recommends women to avoid drug abuse during prenatal and breastfeeding periods

Give up smoking, do not drink more than three cups of coffee per day, do not take any kind of drug, or if you do, take it as long as possible before feeding your baby. These are some of the recommendations contained in a study produced by Spanish researchers on methods for detecting medicines and drugs in breast milk. The study shows that the risk from substances such as alcohol is still not well understood.

24 Jun 2010

Alcohol consumption guidelines during pregnancy needed: Study

Before 2001 Australian health guidelines recommended that pregnant women should not consume alcohol. These guidelines were introduced in 1992. In 2001 the consensus guidelines recommended avoidance of “high” blood levels of alcohol but did not say no to lower levels of alcohol. In 2009 National Health and Medical Research Council advised that all women planning a pregnancy, pregnant or breastfeeding should not drink alcohol at all.

20 Jun 2010

Maternal, infant ART drives down mother-to-child HIV transmission through breast-feeding, studies show

According to two new studies, "giving pregnant and nursing women triple antiretroviral drug therapy, or treating breast-fed infants with an antiretroviral medication, can dramatically cut transmission rates, enabling moms to both breast-feed and to protect nearly all children from infection," HealthDay News/Bloomberg Businessweek reports (Goodwin, 6/16).

18 Jun 2010

Study reveals increase of enzyme MAO-A in female brain during immediate postpartum period

Within the first week after giving birth, up to 70 percent of all women experience symptoms of the baby blues. While most women recover quickly, up to 13 percent of all new mothers suffer from symptoms of a clinical-level postpartum depression. Postpartum depression is defined as a major depressive episode starting within 4 weeks after delivery and is a significant public health problem. Postpartum blues represents a major risk factor for developing postpartum depression and severe postpartum blues symptoms can be viewed as a prodromal stage for postpartum depression.

17 Jun 2010

Infant nevirapine more effective in preventing HIV transmission than maternal antiretroviral therapy

The largest study to date to examine methods to prevent HIV infection among breastfeeding infants concludes that giving antiretroviral drugs to HIV-infected breastfeeding mothers in sub-Saharan Africa or giving an HIV-fighting syrup to their babies are both effective.

17 Jun 2010

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.

14 Jun 2010

Helsinn Healthcare S.A., Eisai announce signing of licensing agreement

Helsinn Healthcare S.A. and Eisai Inc. today announce the signing of a licensing agreement granting Eisai Inc. commercialization rights for a new product for potential use in the prevention of chemotherapy-induced nausea and vomiting in the United States.

9 Jun 2010

Finished school – better health for Indigenous Australians

A new report prepared by the Australian Bureau of Statistics (ABS) has found that indigenous Australians who go on to complete their school education fare much better health wise than those who do not.

8 Jun 2010

Gates Foundation to invest $1.5 billion for integrated women's and children's health programs

Melinda Gates today urged global leaders to make women's and children's health a top priority, and announced that the Gates Foundation will invest $1.5 billion over the next five years to support maternal and child health, family planning, and nutrition programs in developing countries.

8 Jun 2010

30 percent of Aussie mums think it’s OK to drink alcohol while pregnant

A new Australian study has revealed an alarming trend showing one in three pregnant or breastfeeding woman are still drinking alcohol. The Alcohol Education and Rehabilitation Foundation (AERF) feel that in spite of warnings to pregnant women to cut out alcohol completely from their diets, many women are ignoring such warnings.

7 Jun 2010

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADE® (bortezomib) for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). These data highlight VELCADE based therapy in both transplant and non-transplant eligible previously untreated multiple myeloma patients, as well as VELCADE used as induction and/or maintenance therapy.

7 Jun 2010

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Millennium: The Takeda Oncology Company today announced data examining the use of VELCADE in the treatment of patients with relapsed or refractory light chain (AL) amyloidosis. Amyloidosis is a rare condition in which excessive proteins build up in organs or tissues, such as the heart, kidney or liver. These data were presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Illinois, June 4-8, 2010.

5 Jun 2010

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.

4 Jun 2010

Community interventions help American Indian families reduce early childhood weight gain: Study

Community intervention can help American Indian families change behavior related to early childhood weight gain and obesity, according to a new Kaiser Permanente and Northwest Portland Area Indian Health Board study.

3 Jun 2010

Overweight, obesity and low weight affect teenagers' physical fitness

This research was developed by Dr. Enrique Garcia Artero, from the Department of Physiology of the University of Granada, and coordinated by Professor Manuel J. Castillo Garzón. To carry out this project, the researcher used data from the national and European projects AVENA (Food and Assessment of Nutritional Status of Spanish Adolescents) and HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) and ALPHA (Assessing Levels of Physical Activity and Fitness; Public Health Executive Agency).

28 May 2010

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

"Measles is making a rapid comeback in African, Asian and even some European countries despite being easily avoided through vaccination, the World Health Organization said Friday as countries pledged to sharply cut infections and deaths worldwide by 2015," the Associated Press reports (Jordans, 5/22). On the final day of the 63rd Annual World Health Assembly, the assembly endorsed a series of interim targets towards the global eradication of measles, VOA News reports.

25 May 2010

Delegates at the World Health Assembly adopt resolutions on variety of global health issues

The 63rd World Health Assembly, which brought together Health Ministers and senior health officials from the World Health Organization's Member States, concluded business and closed Friday evening.

24 May 2010

New study indicates pregnancy can double HIV risk in men

Young women of reproductive-age are among those at greatest risk of acquiring HIV, and several studies have suggested that during pregnancy women are even more susceptible to infection.

24 May 2010

Breastfeeding News and Research

Latest Breastfeeding News and Research

Data shows Victoza produces greater reductions in A1c, body weight and FPG than Januvia

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Study recommends women to avoid drug abuse during prenatal and breastfeeding periods

Alcohol consumption guidelines during pregnancy needed: Study

Maternal, infant ART drives down mother-to-child HIV transmission through breast-feeding, studies show

Study reveals increase of enzyme MAO-A in female brain during immediate postpartum period

Infant nevirapine more effective in preventing HIV transmission than maternal antiretroviral therapy

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Helsinn Healthcare S.A., Eisai announce signing of licensing agreement

Finished school – better health for Indigenous Australians

Gates Foundation to invest $1.5 billion for integrated women's and children's health programs

30 percent of Aussie mums think it’s OK to drink alcohol while pregnant

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Community interventions help American Indian families reduce early childhood weight gain: Study

Overweight, obesity and low weight affect teenagers' physical fitness

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

Delegates at the World Health Assembly adopt resolutions on variety of global health issues

New study indicates pregnancy can double HIV risk in men

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breastfeeding News and Research

Latest Breastfeeding News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in